Two Sigma Investments’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.42M | Buy |
236,120
+2,312
| +1% | +$26.8K | ﹤0.01% | 2325 |
|
|
2025
Q4 | $2.25M | Buy |
233,808
+153,887
| +193% | +$1.47M | ﹤0.01% | 2351 |
|
|
2025
Q3 | $751K | Buy |
+79,921
| New | +$763K | ﹤0.01% | 2767 |
|
|
2025
Q1 | – | Sell |
-12,096
| Closed | -$199K | – | 3184 |
|
|
2024
Q4 | $199K | Sell |
12,096
-9,240
| -43% | -$182K | ﹤0.01% | 2875 |
|
|
2024
Q3 | $527K | Sell |
21,336
-6,764
| -24% | -$175K | ﹤0.01% | 2453 |
|
|
2024
Q2 | $712K | Sell |
28,100
-19,170
| -41% | -$497K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $1.2M | Sell |
47,270
-12,994
| -22% | -$314K | ﹤0.01% | 1838 |
|
|
2023
Q4 | $1.37M | Buy |
60,264
+42,650
| +242% | +$883K | ﹤0.01% | 1881 |
|
|
2023
Q3 | $328K | Sell |
17,614
-46,936
| -73% | -$973K | ﹤0.01% | 2458 |
|
|
2023
Q2 | $1.68M | Buy |
64,550
+16,145
| +33% | +$432K | ﹤0.01% | 1567 |
|
|
2023
Q1 | $1.39M | Sell |
48,405
-14,227
| -23% | -$423K | ﹤0.01% | 1671 |
|
|
2022
Q4 | $1.85M | Buy |
62,632
+29,879
| +91% | +$850K | 0.01% | 1355 |
|
|
2022
Q3 | $780K | Sell |
32,753
-32,613
| -50% | -$751K | ﹤0.01% | 1573 |
|
|
2022
Q2 | $1.46M | Buy |
65,366
+17,089
| +35% | +$381K | ﹤0.01% | 1355 |
|
|
2022
Q1 | $1.21M | Sell |
48,277
-5,378
| -10% | -$164K | ﹤0.01% | 1614 |
|
|
2021
Q4 | $1.92M | Sell |
53,655
-11,913
| -18% | -$477K | ﹤0.01% | 1948 |
|
|
2021
Q3 | $2.79M | Sell |
65,568
-50,357
| -43% | -$2.07M | 0.01% | 1677 |
|
|
2021
Q2 | $5.02M | Buy |
115,925
+3,142
| +3% | +$134K | 0.01% | 1204 |
|
|
2021
Q1 | $4.6M | Buy |
112,783
+60,549
| +116% | +$2.3M | 0.01% | 1108 |
|
|
2020
Q4 | $2.36M | Buy |
52,234
+7,082
| +16% | +$269K | 0.01% | 1390 |
|
|
2020
Q3 | $1.6M | Buy |
45,152
+17,618
| +64% | +$636K | 0.01% | 1436 |
|
|
2020
Q2 | $1.04M | Sell |
27,534
-548
| -2% | -$18.1K | 0.01% | 1519 |
|
|
2020
Q1 | $812K | Buy |
28,082
+22,707
| +422% | +$918K | 0.01% | 1577 |
|
|
2019
Q4 | $279K | Sell |
5,375
-38,248
| -88% | -$2.22M | ﹤0.01% | 3232 |
|
|
2019
Q3 | $2.39M | Sell |
43,623
-119,882
| -73% | -$6.16M | 0.01% | 1284 |
|
|
2019
Q2 | $6.64M | Sell |
163,505
-15,104
| -8% | -$551K | 0.02% | 774 |
|
|
2019
Q1 | $5.4M | Buy |
178,609
+34,577
| +24% | +$1.18M | 0.02% | 924 |
|
|
2018
Q4 | $4.84M | Sell |
144,032
-15,270
| -10% | -$551K | 0.02% | 818 |
|
|
2018
Q3 | $6.72M | Buy |
159,302
+42,450
| +36% | +$1.68M | 0.02% | 815 |
|
|
2018
Q2 | $3.74M | Buy |
116,852
+98,359
| +532% | +$4.05M | 0.01% | 1186 |
|
|
2018
Q1 | $919K | Buy |
+18,493
| New | +$1.04M | ﹤0.01% | 2064 |
|
|
2017
Q4 | – | Sell |
-11,697
| Closed | -$678K | – | 3064 |
|
|
2017
Q3 | $678K | Sell |
11,697
-56,859
| -83% | -$2.97M | ﹤0.01% | 1958 |
|
|
2017
Q2 | $3.38M | Buy |
68,556
+33,024
| +93% | +$1.52M | 0.01% | 1081 |
|
|
2017
Q1 | $1.54M | Sell |
35,532
-18,589
| -34% | -$887K | 0.01% | 1615 |
|
|
2016
Q4 | $2.65M | Buy |
54,121
+21,076
| +64% | +$974K | 0.01% | 1274 |
|
|
2016
Q3 | $1.58M | Sell |
33,045
-72,948
| -69% | -$3.6M | 0.01% | 1638 |
|
|
2016
Q2 | $5.69M | Sell |
105,993
-46,152
| -30% | -$2.17M | 0.02% | 717 |
|
|
2016
Q1 | $6.8M | Buy |
152,145
+46,041
| +43% | +$1.87M | 0.03% | 585 |
|
|
2015
Q4 | $4.05M | Buy |
106,104
+54,840
| +107% | +$2.1M | 0.02% | 748 |
|
|
2015
Q3 | $1.63M | Buy |
51,264
+40,264
| +366% | +$1.4M | 0.01% | 938 |
|
|
2015
Q2 | $363K | Buy |
+11,000
| New | +$392K | ﹤0.01% | 2312 |
|
|
2014
Q4 | – | Sell |
-6,795
| Closed | -$249K | – | 2205 |
|
|
2014
Q3 | $249K | Sell |
6,795
-10,117
| -60% | -$437K | ﹤0.01% | 1532 |
|
|
2014
Q2 | $784K | Buy |
+16,912
| New | +$752K | ﹤0.01% | 1427 |
|
|
2014
Q1 | – | Sell |
-5,300
| Closed | -$202K | – | 1964 |
|
|
2013
Q4 | $202K | Sell |
5,300
-100,894
| -95% | -$3.11M | ﹤0.01% | 2010 |
|
|
2013
Q3 | $2.54M | Buy |
106,194
+53,276
| +101% | +$1.2M | 0.02% | 715 |
|
|
2013
Q2 | $900K | Buy |
+52,918
| New | +$763K | 0.01% | 1168 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Two Sigma Investments's ANIK Position: Q1 2026 in Review
Two Sigma Investments increased its Anika Therapeutics (ANIK) stake by 0.99% in Q1 2026, buying an estimated $26.8K and bringing the position to 236,120 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2325.
Two Sigma Investments first reported a position in ANIK in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.8M in Q1 2016. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Two Sigma Investments held 236,120 shares of Anika Therapeutics worth $3.42M as of Q1 2026.
- Two Sigma Investments bought 2,312 Anika Therapeutics shares in Q1 2026, an estimated $26.8K.
- Anika Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2325 holding.
- Two Sigma Investments first reported a position in Anika Therapeutics in Q2 2013 and has held it in 46 quarters since.
- Two Sigma Investments's Anika Therapeutics position peaked at $6.8M in Q1 2016.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.